CONMED Corp. (CNMD)
37.56
+0.24
(+0.64%)
USD |
NYSE |
May 07, 09:31
CONMED Cash from Investing (Quarterly) : 4.108M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Escalon Medical Corp. | 0.00 |
| IRIDEX Corp. | -0.106M |
| Electromed, Inc. | -0.656M |
| Guided Therapeutics, Inc. | 0.00 |
| Axogen, Inc. | -15.96M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 13.47M |
| Cash from Financing (Quarterly) | -22.55M |
| Free Cash Flow | 123.71M |
| Free Cash Flow Per Share (Quarterly) | 0.3455 |
| Free Cash Flow to Equity (Quarterly) | 37.20M |
| Free Cash Flow to Firm (Quarterly) | 15.90M |
| Free Cash Flow Yield | 10.65% |